The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers Polling Results for CLASS I Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class I Guidelines
1. Use of angiotensin receptor blockers is recommended in patients who are intolerant of ACE inhibitors and have HF or have had an MI with LVEF ≤40%. (Class I Level of Evidence: A)

 AHA / ACC 2007 PCI Guidelines Class I Recommendation 1 for Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers should be CLASS I CLASS IIa CLASS IIb CLASS III

2. Angiotensin receptor blockers are useful in other patients who are ACE-inhibitor intolerant and have hypertension. (Class I Level of Evidence: B)

 AHA / ACC 2007 PCI Guidelines Class I Recommendation 2 for Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers should be CLASS I CLASS IIa CLASS IIb CLASS III